<DOC>
	<DOCNO>NCT00875628</DOCNO>
	<brief_summary>Investigation safety , tolerability , pharmacokinetics PF-00868554 follow multiple oral administration PF-00868554 Japanese healthy adult volunteer .</brief_summary>
	<brief_title>A Study To Investigate Safety , Tolerability , And Pharmacokinetics Of PF-00868554 In Japanese Healthy Adult Volunteers</brief_title>
	<detailed_description>Study A8121018 prematurely discontinue due FDA instruction state Study A8121018 could perform US IND 78,910 , provide meeting August 13 , 2009 . And termination decide Pfizer September 8 , 2009 prior subject dose PF-00868554 . There safety concern regard study decision terminate trial .</detailed_description>
	<criteria>Healthy male female Japanese subject age 18 55 year . Body Mass Index ( BMI ) 17.5 30.5 kg/m2 ; total body weight &gt; 50 kg ( 110 lb ) . Male subject history subfertility/infertility condition opinion investigator may affect fertility . Exposure within previous three month drug know negative effect skeletal muscle reproductive organ . Pregnant nursing female ; female childbearing potential .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>October 2009</verification_date>
	<keyword>Japanese Healthy volunteer HCV pharmacokinetics PF-00868554 filibuvir</keyword>
</DOC>